GENNIEFY
Market News
Latest financial news and analysis from global markets
MSFT
Microsoft Q3 Earnings Call Highlights
Microsoft (NASDAQ:MSFT) executives told investors the company delivered a “record third quarter,” fueled by continued demand for cloud services and accelerating adoption of its AI offerings, while acknowledging that capacity constraints and heavy infrastructure investment remain central themes headi
INTC
3 Phenomenal AI Stocks for Maximum Upside
Nvidia, Nebius, and IonQ each have massive potential, but they come with some risks for shareholders.
NVDA
3 Phenomenal AI Stocks for Maximum Upside
Nvidia, Nebius, and IonQ each have massive potential, but they come with some risks for shareholders.
NVDA
Samsung Electronics sees robust AI demand after Q1 profit surges eightfold to set record
SEOUL, April 30 () - Samsung Electronics said on Thursday its operating profit jumped eightfold to a record in the first quarter, underpinned by higher chip prices as an artificial intelligence boom led to a supply crunch. Samsung expects earnings to improve further in the second quarter, saying investment in AI infrastructure would continue to expand, driving up memory chip prices.
ADBE
Stronger Q1 Results and New AI Alliances Could Be A Game Changer For Omnicom Group (OMC)
Omnicom Group has reported first-quarter 2026 results, with sales rising to US$6,242.9 million and net income to US$405.2 million, while earnings per share from continuing operations edged lower year on year. At the same time, Omnicom is deepening its use of generative AI through new collaborations with Google Cloud and Adobe, aiming to embed automated content vetting and enterprise-grade AI workflows across its marketing platforms. Now we’ll examine how Omnicom’s stronger quarterly...
BMY
Does BMS–Foundation Medicine’s MTAP CDx Partnership Expansion Change The Bull Case For Bristol-Myers Squibb (BMY)?
In recent weeks, Foundation Medicine announced it expanded its collaboration with Bristol Myers Squibb to develop FoundationOne CDx as a next-generation sequencing-based companion diagnostic for identifying patients with homozygous MTAP deletion across multiple indications for an investigational targeted therapy. This move underscores Bristol Myers Squibb’s push deeper into precision oncology, linking its targeted drug development to advanced genomic testing that can help match complex tumor...
INTC
Why Biogen Stock Was a Winner on Wednesday
The biotech's growth portfolio continues to add to its overall top line.
NVDA
Why Biogen Stock Was a Winner on Wednesday
The biotech's growth portfolio continues to add to its overall top line.
TSLA
Rivian CEO walks away with $403 million despite huge losses
There is a long tradition in American business of paying executives more than the company itself has earned. It gets defended on the grounds that great talent must be lured, that risk must be rewarded, or that the future will somehow erase the present. Most of the time, the math eventually catches ...
INTC
Bitcoin Is Moving From Trade to Treasury Asset -- Here's Why That Matters
Starting at the individual level first, the leading cryptocurrency's evolution hasn't been like typical financial assets.
BTCUSDT
Bitcoin Is Moving From Trade to Treasury Asset -- Here's Why That Matters
Starting at the individual level first, the leading cryptocurrency's evolution hasn't been like typical financial assets.
NVDA
Bitcoin Is Moving From Trade to Treasury Asset -- Here's Why That Matters
Starting at the individual level first, the leading cryptocurrency's evolution hasn't been like typical financial assets.